Bio-Connect
WB analysis of EL4 cell lysate using GTX85160 NOD4 antibody. Working concentration : 1 microg/ml
WB analysis of EL4 cell lysate using GTX85160 NOD4 antibody. Working concentration : 1 microg/ml
WB analysis of EL4 cell lysate using GTX85160 NOD4 antibody. Working concentration : 1 microg/ml

NOD4 antibody

GTX85160
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry
Product group Antibodies
TargetNLRC5
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    NOD4 antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1 microg/mL. ICC/IF: 10 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID84166
  • Target name
    NLRC5
  • Target description
    NLR family CARD domain containing 5
  • Target synonyms
    CLR16.1, NOD27, NOD4, protein NLRC5, NOD-like receptor C5, caterpiller protein 16.1, nucleotide-binding oligomerization domain protein 4, nucleotide-binding oligomerization domain, leucine rich repeat and CARD domain containing 5, nucleotide-binding oligomerization domains 27
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ86WI3
  • Protein Name
    Protein NLRC5
  • Scientific Description
    NOD4 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD4 contains a CARD-like domain, a central NOD domain and a large LRR region. NOD4, an IFN-gamma-inducible nuclear protein, plays a role in homeostatic control of innate immunity and in antiviral defense mechanisms. As a key negative regulator of NF-ases, including cancer.
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Liang S, Xiang T, Liu S, et al. Inhibition of NLRC5 attenuates the malignant growth and enhances the sensitivity of gastric cancer cells to 5-FU chemotherapy by blocking the carcinogenic effect of YY1. Exp Ther Med. 2022,24(3):601. doi: 10.3892/etm.2022.11538
    Read this paper